Review
Open access
Aug 2026
Bad Blood: Navigating VTE Risk in Breast, Ovarian, and Endometrial Cancer
Advances in biomarkers, molecular profiling, and artificial intelligence-based predictive tools are expected to further enhance personalized prevention strategies and improve clinical outcomes in patients with hormone-sensitive malignancies.
F. Sorrentino, Laura Vona, L. Nappi et al.
· Cancers · 0 citations